Reduced Congestion and Improved Response to a Fluid/Sodium Challenge in Chronic Heart Failure Patients After Initiation of Sacubitril/Valsartan: The NATRIUM-HF Study
European Journal of Heart Failure · 2024
DOI: 10.1002/ejhf.3265 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Heart Failure, 2024. Verfasst von Alexandre Mebazaa und 12 weiteren Autor:innen. Beteiligte Einrichtung: U 942 Inserm MASCOT, Paris, France. Hauptthemen laut MEDLINE: Valsartan, Biphenyl Compounds, Aminobutyrates, Heart Failure. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Abbott Laboratories.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
The effects of initiating sacubitril/valsartan in patients with stable heart failure with reduced ejection fraction (HFrEF) on response to fluid and sodium expansion are unknown. Methods and results We have explored changes in natriuresis, diuresis, and congestion in response to the administration of intravenous fluid/sodium load in patients with HFrEF before as compared to after the initiation of sacubitril/valsartan. At baseline (before sacubitril/valsartan initiation) and 2 and 3 months after the initiation, patients underwent an evaluation that consisted of three phases of 3 h: the rest phase (0–3 h), the load phase (3–6 h) in which 1 L of intravenous Ringer solution was administered, and the diuretic phase (6–9 h) at the beginning of which furosemide was administered. Overall, 216 patients completed the study. In comparison to baseline values, at 2 and 3 months after sacubitril/valsartan initiation, patients' diuresis and natriuresis in response to Ringer administration significantly increased (mean difference: 38.8 [17.38] ml, p = 0.0040, and 9.6 [2.02] mmol, p < 0.0001, respectively). Symptoms and signs of congestion after the fluid/sodium challenge were significantly decreased at months 2 and 3 compared to baseline. Compared to baseline, there was also an increment of natriuresis after furosemide administration on sacubitril/valsartan (9.8 [5.13] mmol, p = 0.0167). There was a significant decrease in body weight in subsequent visits when compared to baseline values (−0.50 [−12.7, 7.4] kg at 2 months, and −0.75 [−15.9, 7.5] kg at 3 months; both p < 0.0001).
Conclusions
The initiation of sacubitril/valsartan in HFrEF patients was associated with improvements in natriuresis, diuresis, and weight loss and better clinical adaptation to potentially decongestive stressors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- U 942 Inserm MASCOT, Paris, France.
- Department of Anesthesiology and Critical Care Medicine, AP-HP, Saint Louis Lariboisière University Hospitals, Université de Paris, Paris, France.
- Momentum Research, Inc., Durham, NC, USA.
- Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
- Abbott Laboratories Abbott Park, Chicago, IL, USA.
- Cardiology Center of Erebouni MC, Yerevan State Medical University, Yerevan, Armenia.
ORCID-Profile: Koji Takagi
Förderung
- Abbott Laboratories
Zitieren
APA
Mebazaa, A., Davison, B. A., Biegus, J., Edwards, C., Murtagh, G., Varounis, C., Hayrapetyan, H., Sisakian, H., Ter-Grigoryan, V. R., Takagi, K., Novosadova, M., Ponikowski, P., & Cotter, G. (2024). Reduced Congestion and Improved Response to a Fluid/Sodium Challenge in Chronic Heart Failure Patients After Initiation of Sacubitril/Valsartan: The NATRIUM-HF Study. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3265
Vancouver
Mebazaa A, Davison BA, Biegus J, Edwards C, Murtagh G, Varounis C, et al. Reduced Congestion and Improved Response to a Fluid/Sodium Challenge in Chronic Heart Failure Patients After Initiation of Sacubitril/Valsartan: The NATRIUM-HF Study. European Journal of Heart Failure. 2024. doi:10.1002/ejhf.3265
BibTeX
@article{Mebazaa2024,
author = {Mebazaa, Alexandre and Davison, Beth A and Biegus, Jan and Edwards, Christopher and Murtagh, Gillian and Varounis, Christos and Hayrapetyan, Hamlet and Sisakian, Hamayak and Ter-Grigoryan, Victor R and Takagi, Koji and Novosadova, Maria and Ponikowski, Piotr and Cotter, Gad},
title = {Reduced Congestion and Improved Response to a Fluid/Sodium Challenge in Chronic Heart Failure Patients After Initiation of Sacubitril/Valsartan: The NATRIUM-HF Study},
journal = {European Journal of Heart Failure},
year = {2024},
doi = {10.1002/ejhf.3265}
}
EUVIMED